MedPath

Study comparing efficacy of two drugs as first line drug in late preterm and term babies with Neonatal Seizure.

Not Applicable
Conditions
Health Condition 1: G404- Other generalized epilepsy and epileptic syndromes
Registration Number
CTRI/2023/02/049794
Lead Sponsor
TATA MAIN HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All term and late pre-term neonates ( >35weeks of gestation) with clinically apparent seizures and lasting for 3 minutes.

Exclusion Criteria

Neonates-

1. Who had received any previous anticonvulsants.

2. With correctable metabolic abnormalities(like hypoglycemia/hypocalcemia)

3. With myoclonic jerks.

4. With major congenital malformation or syndromes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath